APA Alıntı

Whicker, M. E., Lin, Z. P., Hanna, R., Sartorelli, A. C., & Ratner, E. S. (2016). MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib. BMC Cancer.

Chicago Stili Alıntı

Whicker, Margaret E., Z. Ping Lin, Ruth Hanna, Alan C. Sartorelli, ve Elena S. Ratner. "MK-2206 Sensitizes BRCA-deficient Epithelial Ovarian Adenocarcinoma to Cisplatin and Olaparib." BMC Cancer 2016.

MLA Alıntı

Whicker, Margaret E., et al. "MK-2206 Sensitizes BRCA-deficient Epithelial Ovarian Adenocarcinoma to Cisplatin and Olaparib." BMC Cancer 2016.